Detalles de la búsqueda
1.
A randomized, double-blind trial assessing the efficacy and safety of two doses of dulaglutide in Japanese participants with type 2 diabetes (AWARD-JPN).
Diabetes Obes Metab
; 2024 May 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-38715179
2.
Change in pharmacodynamic variables following once-weekly tirzepatide treatment versus dulaglutide in Japanese patients with type 2 diabetes (SURPASS J-mono substudy).
Diabetes Obes Metab
; 25(2): 398-406, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36184780
3.
Glucose-dependent insulinotropic polypeptide counteracts diet-induced obesity along with reduced feeding, elevated plasma leptin and activation of leptin-responsive and proopiomelanocortin neurons in the arcuate nucleus.
Diabetes Obes Metab
; 25(6): 1534-1546, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36852745
4.
Evaluation of the impact of once weekly dulaglutide on patient-reported outcomes in Japanese patients with type 2 diabetes: comparisons with liraglutide, insulin glargine, and placebo in two randomized studies.
Health Qual Life Outcomes
; 15(1): 123, 2017 Jun 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-28606095
5.
Efficacy and safety of subgroup analysis stratified by baseline HbA1c in a Japanese phase 3 study of dulaglutide 0.75 mg compared with insulin glargine in patients with type 2 diabetes.
Endocr J
; 64(12): 1165-1172, 2017 Dec 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-28904247
6.
Efficacy and safety analyses across 4 subgroups combining low and high age and body mass index groups in Japanese phase 3 studies of dulaglutide 0.75 mg after 26 weeks of treatment.
Endocr J
; 64(4): 449-456, 2017 Apr 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-28302958
7.
The combination of dulaglutide and biguanide reduced bodyweight in Japanese patients with type 2 diabetes.
Diabetes Obes Metab
; 18(12): 1279-1282, 2016 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-27488246
8.
Subgroup analysis of phase 3 studies of dulaglutide in Japanese patients with type 2 diabetes.
Endocr J
; 63(3): 263-73, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-26698689
9.
A 1-year safety study of dulaglutide in Japanese patients with type 2 diabetes on a single oral hypoglycemic agent: an open-label, nonrandomized, phase 3 trial.
Endocr J
; 62(12): 1101-14, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26477324
10.
Monotherapy with the once weekly GLP-1 receptor agonist dulaglutide for 12 weeks in Japanese patients with type 2 diabetes: dose-dependent effects on glycaemic control in a randomised, double-blind, placebo-controlled study.
Endocr J
; 61(10): 949-59, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-25029955
11.
Metabolic Abnormalities Following Tirzepatide Monotherapy in Japanese Patients with Type 2 Diabetes: A Phase 3 SURPASS J-mono Post Hoc Analysis.
Diabetes Ther
; 15(3): 649-661, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38310163
12.
Efficacy and safety of stepwise introduction of insulin lispro mix 50 in Japanese patients with type 2 diabetes inadequately controlled by oral therapy.
Endocr J
; 60(6): 763-72, 2013.
Artículo
en Inglés
| MEDLINE | ID: mdl-23459461
13.
Treatment Satisfaction and Quality of Life with Tirzepatide Versus Dulaglutide Among Japanese Patients with Type 2 Diabetes: Exploratory Evaluation of the SURPASS J-mono Trial.
Diabetes Ther
; 14(12): 2173-2183, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37843771
14.
Changes in prescription patterns and doses of oral antidiabetic drugs in Japanese patients with type 2 diabetes (JDDM70).
J Diabetes Investig
; 14(1): 75-80, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-36268571
15.
Efficacy and safety of tirzepatide monotherapy compared with dulaglutide in Japanese patients with type 2 diabetes (SURPASS J-mono): a double-blind, multicentre, randomised, phase 3 trial.
Lancet Diabetes Endocrinol
; 10(9): 623-633, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35914543
16.
Efficacy and Safety of Once-Weekly Dulaglutide in Type 2 Diabetes Patients Using Insulin: Exploratory Subgroup Analysis by Insulin Regimen.
Diabetes Ther
; 11(3): 735-745, 2020 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-31994009
17.
Once-Weekly Dulaglutide with Insulin Therapy for Type 2 Diabetes: Efficacy and Safety Results from a Phase 4, Randomized, Placebo-Controlled Study.
Diabetes Ther
; 11(1): 133-145, 2020 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-31758520
18.
Cast: a novel protein of the cytomatrix at the active zone of synapses that forms a ternary complex with RIM1 and munc13-1.
J Cell Biol
; 158(3): 577-90, 2002 Aug 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-12163476
19.
Effect of Once-Weekly Dulaglutide on Glucose Levels in Japanese Patients with Type 2 Diabetes: Findings from a Phase 4, Randomized Controlled Trial.
Diabetes Ther
; 10(3): 1019-1027, 2019 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-30949907
20.
Nectin-dependent localization of ZO-1 at puncta adhaerentia junctions between the mossy fiber terminals and the dendrites of the pyramidal cells in the CA3 area of adult mouse hippocampus.
J Comp Neurol
; 460(4): 514-24, 2003 Jun 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-12717711